Susquehanna International Group, LLP Bioventus Inc. Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
A detailed history of Susquehanna International Group, LLP transactions in Bioventus Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 27,292 shares of BVS stock, worth $213,423. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,292
Previous 83,000
67.12%
Holding current value
$213,423
Previous $991,000
71.14%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding BVS
# of Institutions
160Shares Held
45.3MCall Options Held
252KPut Options Held
72.5K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$102 Million31.61% of portfolio
-
Juniper Investment Company, LLC New York, NY6.94MShares$54.3 Million28.32% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.03MShares$31.5 Million2.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.46MShares$19.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$18.5 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $482M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...